Reduced sensitivity of staphylococcus aureus to vancomycin
Authors
Abstract:
Introduction: Staphylococcus aureus is one of the most common causes of infections in hospitals and vancomycin is used for the treatment of methicillin resistant S, aureus infections. Therefore, imergence of Staphylococcus aureus with reduced sensitivity to vancomycin is a serious problem. The aim of this study was to investigate the prevalence of Staphylococcus aureus with reduced susceptibility to Vancomycin and to determine of their antibiogram patterns. Methods: This descriptive cross-sectional study was performed in a period of one year and 104 strains of S.aureus were determined on the basis of gram staining, susceptibility to Novobiocin, production of catalase, coagulase and DNase. Susceptibility pattern to Vancomycin and others antibiotics by disk diffusion and MICs were determined by agar dilution methods, according to CLSI. Results: The highest sensitivity rates were observed to vancomycin (96.2%) chloramphenicol (88.5%), and rifampicin (81.7%). Prevalence of MRSA was 40.4%. The rate of VISA was 4 (3.8%). Conclusion: We recommend that clinicians must be aware of management of patients who are colonized or infected with VISA and VRSA and early detection of VISA and VRSA isolates should be considered at the earliest.
similar resources
Staphylococcus aureus with Reduced Susceptibility to Vancomycin
Infections with Staphylococcus aureus with reduced susceptibility to vancomycin continue to be reported, including 2 cases caused by S. aureus isolates with full resistance to vancomycin. This review first outlines the definitions of vancomycinintermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) and risk factors for infection. Next, we describe the mechanisms of resistance an...
full textStaphylococcus aureus with reduced susceptibility to vancomycin.
Infections with Staphylococcus aureus with reduced susceptibility to vancomycin continue to be reported, including 2 cases caused by S. aureus isolates with full resistance to vancomycin. This review first outlines the definitions of vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) and risk factors for infection. Next, we describe the mechanisms of resistance a...
full textReduced Susceptibility to Vancomycin in Staphylococcus aureus
Our report highlights an alarming situation in Réunion Island. Reemergence of CS after the increase of early syphilis in women of childbearing age must be considered as a public health alert, especially in countries where health care is supposed to be effi cient. CS is easy to prevent with adequate screening of the mother and good follow-up of seropositive parturients. The results of our study ...
full textStaphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings
Glycopeptide resistance in Staphylococcus aureus is a source of great concern because, especially in hospitals, this class of antibiotics, particularly vancomycin, is one of the main resources for combating infections caused by methicillin-resistant Staphylococcus aureus strains (MRSA). Reduced susceptibility to vancomycin (VISA) was first described in 1996 in Japan; since then, a phenotype wit...
full textEndocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
Clinical management of infective endocarditis (IE) is expected to become more difficult with the emergence of Staphylococcus aureus with reduced susceptibility to vancomycin (SARV) in the United States and worldwide. We report the strain characterization and treatment of a patient with SARV IE.
full textReduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.
In the present study, we demonstrated the utility of the nonmammalian model system Galleria mellonella for studying the pathogenesis of Staphylococcus aureus infection. By use of clinical and laboratory strains that had been exposed to vancomycin, we showed that both agr functional status and vancomycin minimum inhibitory concentration are determinants associated with the virulence of S. aureus...
full textMy Resources
Journal title
volume 15 issue None
pages 169- 177
publication date 2011-10
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023